Dylan Conklin
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
-
- Advanced Breast Cancer Therapies
Papers in
- Oncology 19
- Cancer-related Molecular Pathways 7
- PARP inhibition in cancer therapy 6
- HER2/EGFR in Cancer Research 5
-
- Advanced Breast Cancer Therapies 10
- Co-authors
- Dennis J. Slamon (30 shared papers)Ondrej Kalous (13 shared papers)Richard S. Finn (12 shared papers)Amrita Desai (7 shared papers)Charles Ginther (5 shared papers)David J. Cohen (2 shared papers)Judy Dering (4 shared papers)Isan Chen (1 shared paper)
- Journals
- Cancer Research (12 papers)Molecular Cancer Therapeutics (3 papers)Journal of Clinical Oncology (2 papers)Breast Cancer Research and Treatment (2 papers)Breast Cancer Research (2 papers)
- Partner nations
- United StatesSwitzerlandIreland
In The Last Decade
Dylan Conklin
32 papers receiving 1.8k citations
Dylan Conklin's Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 979
- Pulmonary and Respiratory Medicine 1.0k
- Cancer Research 333
- Genetics 204
- Molecular Biology 567
Countries citing papers authored by Dylan Conklin
This map shows the geographic impact of Dylan Conklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dylan Conklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dylan Conklin more than expected).
Fields of papers citing papers by Dylan Conklin
This network shows the impact of papers produced by Dylan Conklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dylan Conklin. The network helps show where Dylan Conklin may publish in the future.
Co-authors
The 25 scholars most cited alongside Dylan Conklin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro Hit paper breakdown → | 2009 | 1063 |
| 2 | 2018 | 99 | |
| 3 | 2014 | 96 | |
| 4 | 2020 | 92 | |
| 5 | PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity. | 2013 | 89 |
| 6 | 2018 | 82 | |
| 7 | 2018 | 77 | |
| 8 | 2012 | 60 | |
| 9 | 2013 | 58 | |
| 10 | 2015 | 46 | |
| 11 | 2017 | 27 | |
| 12 | 2013 | 22 | |
| 13 | 2015 | 8 | |
| 14 | 2013 | 6 | |
| 15 | 2018 | 6 | |
| 16 | 2017 | 4 | |
| 17 | 2014 | 4 | |
| 18 | 2015 | 3 | |
| 19 | 2016 | 3 | |
| 20 | Abstract #5494: Pre-clinical evaluation of single-agent activity of the PARP inhibitor olaparib (AZD2281) in homologous recombination deficient triple-negative breast cancer | 2009 | 1 |
About Dylan Conklin
Dylan Conklin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Cancer Research, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (10 papers), Cancer-related Molecular Pathways (7 papers), PARP inhibition in cancer therapy (6 papers), HER2/EGFR in Cancer Research (5 papers), DNA Repair Mechanisms (3 papers), Melanoma and MAPK Pathways (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Oncology (979 citations), Pulmonary and Respiratory Medicine (1.0k citations), Cancer Research (333 citations), Genetics (204 citations) and Molecular Biology (567 citations). Dylan Conklin has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Dennis J. Slamon, Ondrej Kalous, Richard S. Finn, Amrita Desai, Charles Ginther, David J. Cohen, Judy Dering, Isan Chen, Camilla Fowst and Mohammad Atefi. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Clinical Oncology, Breast Cancer Research and Treatment and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.